BIOA

Conviction 100HealthcareScan · Fri, Jun 26, 2026

BIOA$23.72+4.84%

ResistanceSupportVol 14

Vol MA14 692.78K

Mar 27Apr 15May 4May 20Jun 9Jun 26

BioAge Labs, Inc.PHARMACEUTICAL PREPARATIONSwww.bioagelabs.com ↗

Price23.72

Change+4.84%

Gap-0.27%

Rel volume4.88×

Avg volume576.99K

Avg $ vol11.71M

SMA 2018.76

SMA 5017.97

SMA 20014.45

Price vs 50+31.98%

Price vs 200+64.16%

MA stackbullish

50/200 cross—

Supertrendup · 19.04

RSI (14)74

MACD hist0.64

MACD crossbull · 9d

Stoch %K / %D88 / 86

ADX (14)31

+DI / −DI36 / 8

RSI divergence—

MACD divergence—

ATR %+6.08%

ADR %7.27%

52w high23.72

52w low4.12

From 52w high+0.00%

Above 52w low+475.61%

New 52w highYes

SqueezeOff

Bollinger width58.60%

%B0.95

Donchian pos87.60%

Donchian high24.93

Donchian low15.14

AVWAP (52w high)23.35

vs AVWAP high+1.58%

AVWAP (52w low)15.17

vs AVWAP low+56.32%

OBV trendUp

Chaikin MF (20)0.34

Today vs 20d4.88×

Avg vol (14d)692.78K

Avg vol (20d)576.99K

Avg $ vol (20d)11.71M

Market cap—

RS 3m (vs SPY)+26.05%

RS 6m (vs SPY)+59.34%

RS line new highNo

Trend template8/8

Technical rank95.1

1 week+14.18%

1 month+39.91%

3 months+45.94%

6 months+79.52%

1 year+454.09%

YTD+84.84%

P/E-12.45

P/B2.65

P/S111.56

P/FCF-12.19

EPS-2.24

Div yield—

ROE-21.26%

ROA-20.27%

Debt/Eq0.00

Current24.76

EV/EBITDA—

Gross margin—

Net margin-896.11%

Rev growth—

EPS growth-13.35%

Price target42.20

Target upside86.93%

Analyst ratingBuy

Institutional81.25%

Ent. value762.9M

Revenue2.77M

Net income-22.25M

Gross profit—

Free cash flow-82.35M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out44.45M

Employees62

ListedThu, Sep 26, 2024

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank95.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance19.09

Support14.93

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BIOA

All disclosures →

No recent disclosed trades by Congress in BIOA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BIOA · 1 buy · 1 sell

Insider	Side	Shares	Value	Traded	Filed
GOLDSTEIN DOV A MD Chief Financial Officer · Common Stock · 2026-04-23	Exercise	3.54K	$16K	2026-04-23	2026-04-24
GOLDSTEIN DOV A MD Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-23	Exercise	3.54K	$0	2026-04-23	2026-04-24

SEC filings

EDGAR filings in BIOA · 1 recent

EDGAR →

8-K8-KFri, Jun 12, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.